IgSF: A Potential Drug Target for Immune and Cellular Processes

Target Name: Immunoglobulin-Like Domain Containing Receptor

NCBI ID: P45300

Immunoglobulin-Like Domain Containing Receptor

Other Name(s): IgSF

IgSF: A Potential Drug Target for Immune and Cellular Processes

The Immunoglobulin-Like Domain Containing Receptor (IgSF) is a protein that is expressed in various tissues throughout the body. It is a member of the immunoglobulin superfamily and is characterized by the presence of an IgSF-like domain, as well as several Ig- like domains. IgSF is involved in many different cellular processes in the body, including inflammation, immune response, and cell signaling. As a result, it is a potential drug target and may be useful as a biomarker for certain diseases.

The IgSF gene is located on chromosome 14 and encodes a protein that is made up of several subunits. The subunits include a constant region, a variable region, and an IgSF-like domain. The constant region consists of 126 amino acids and is responsible for maintains the overall structure of the protein. The variable region consists of 284 amino acids and is responsible for the recognition of specific antigens. The IgSF-like domain is a short, acidic region that is similar to the IgSF-1 and IgSF-2 domains found in other immunoglobulins.

IgSF is involved in many different cellular processes in the body. It is a key regulator of inflammation, and it is involved in the development and maintenance of an immune response. It is also involved in cell signaling, and it plays a role in the regulation of cell growth and differentiation. In addition, IgSF is involved in the regulation of cell survival and cytoskeletal organization.

One of the key functions of IgSF is its role in inflammation. It is involved in the regulation of inflammation by promoting the recruitment of immune cells to the site of injury or infection. IgSF also plays a role in the regulation of inflammation by promoting the production of pro-inflammatory cytokines. These cytokines help to recruit additional immune cells to the site of injury or infection, which can help to further exacerbate the inflammatory response.

IgSF is also involved in the regulation of cell signaling. It is a key regulator of the T cell response to antigens, and it is involved in the development and maintenance of tolerance. IgSF also plays a role in the regulation of cell signaling by promoting the production of signaling molecules, such as T cell determinant (TLR) ligands. These signaling molecules help to coordinate the immune response and are involved in the regulation of inflammation.

In addition to its role in inflammation and signaling, IgSF is also involved in the regulation of cell survival and cytoskeletal organization. It is a key regulator of cell cycle progression, and it is involved in the regulation of cell growth and differentiation. IgSF also plays a role in the regulation of cell survival by promoting the production of cell survival factors and by inhibiting the production of pro-apoptotic proteins.

IgSF is also involved in the regulation of cytoskeletal organization. It is a key regulator of actin dynamics and is involved in the regulation of cell movement. IgSF also plays a role in the regulation of cytoskeletal organization by promoting the production of microtubules and by inhibiting the production of actinin.

IgSF is a protein that is expressed in various tissues throughout the body and is involved in many different cellular processes in the body. It is a potential drug target and may be useful as a biomarker for certain diseases. Further research is needed to fully understand the role of IgSF in the immune system and to develop effective treatments for diseases that are caused by its dysfunction.

Protein Name: Immunoglobulin-Like Domain Containing Receptor (nonspecified Subtype)

The "Immunoglobulin-Like Domain Containing Receptor Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Immunoglobulin-Like Domain Containing Receptor comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets